RIA
DALS

RP Investment Advisors’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

RP Investment Advisors’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-415,591
Closed -$4.04M – 86
2022
Q3 		$4.04M Hold
415,591
– – 1.01% 57
2022
Q2 		$4.03M Buy
415,591
+6,735
+2% +$65.5K 0.57% 76
2022
Q1 		$3.97M Buy
408,856
+354,569
+653% +$3.42M 0.56% 84
2021
Q4 		$533K Buy
+54,287
New +$532K 0.07% 96

Other funds holding DALS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

RP Investment Advisors's DALS Position: Q4 2022 in Review

RP Investment Advisors sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q4 2022, closing a stake of 415,591 shares — an estimated $4.04M sold.

RP Investment Advisors first reported a position in DALS in Q4 2021 and held it in 4 quarters. The position peaked at $4.04M in Q3 2022. 47 funds tracked by Wall St. Rank hold DALS as of Q4 2022.

  • RP Investment Advisors reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • RP Investment Advisors sold 415,591 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $4.04M.
  • RP Investment Advisors first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 4 quarters.
  • RP Investment Advisors's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $4.04M in Q3 2022.
  • 47 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on RP Investment Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.